Targeted Cancer Therapy: An application of Impramine Blue (IB) Lipsomes in Cancer Treatment

Show simple item record

dc.contributor.author White, Terrance en_US
dc.date.accessioned 2011-08-16T14:32:40Z
dc.date.available 2011-08-16T14:32:40Z
dc.date.issued 2011-08-04
dc.identifier.uri http://hdl.handle.net/1853/40590
dc.description Ravi Bellamkonda Lab en_US
dc.description Presented on August 4, 2011 from 9:00 am to 11:30 am in room 1107 of the Parker H. Parker Petit Institute for Bioengineering and Bioscience. en_US
dc.description Runtime: 16:43 minutes en_US
dc.description.abstract Cancer has become a major topic of research in the search to find a cure that is effective. Described as a group of diseases that are characterized by the uncontrollable growth of cells, cancer is known to be the second major leading cause of death in the world behind heart disease. There are many therapeutic treatments for cancer such as surgery, chemotherapy, immunotherapy and radiation. However, a major concern arises when there are apparent side effects from such treatments. Therefore, targeted therapy, which utilizes nanoparticles to deliver drugs directly to the tumor region by way of the enhanced permeability and retention effect, has become an area of interest. The Bellamkonda Lab at Georgia Institute of Technology focuses on liposomal nanoparticles to deliver an anti brain tumor drug, Imipramine blue, directly to tumor sites. There have been many laboratory investigations concerning the toxicity and effectiveness of the Imipramine blue liposomes. As a result, they have proven to yield adequate results by inhibiting the growth of tumor cells and prolonging the Imipramine blue life span in the blood stream. en_US
dc.format.extent 16:43 minutes en_US
dc.language.iso en_US en_US
dc.publisher Georgia Institute of Technology en_US
dc.subject Targeted cancer therapy en_US
dc.title Targeted Cancer Therapy: An application of Impramine Blue (IB) Lipsomes in Cancer Treatment en_US
dc.type Presentation en_US
dc.type Video en_US
dc.contributor.corporatename Georgia Institute of Technology. Emergent Behavior of Integrated Cellular Systems en_US
dc.contributor.corporatename Georgia Institute of Technology. Dept. of Biomedical Engineering en_US
dc.contributor.corporatename Emory University. Dept. of Biomedical Engineering en_US
dc.description.advisor Balakrishna Pai-Mentor en_US


Files in this item

Files Size Format View Description
06 white.mp4 47.16Mb MPEG-4 video View/ Open Download Video
06white_streaming.html 938bytes HTML View/ Open Streaming Video

This item appears in the following Collection(s)

Show simple item record